Aprica Healthcare Profile
Key Indicators
- Authorised Capital ₹ 9.90 Cr
as on 04-10-2024
- Paid Up Capital ₹ 9.51 Cr
as on 04-10-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.00 Cr
as on 04-10-2024
- Revenue -4.83%
(FY 2023)
- Profit -57.61%
(FY 2023)
- Ebitda -52.58%
(FY 2023)
- Net Worth 4.69%
(FY 2023)
- Total Assets 0.09%
(FY 2023)
About Aprica Healthcare
The Corporate was formerly known as Emcure Uth Healthcare Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.90 Cr and a paid-up capital of Rs 9.51 Cr.
The company has closed loans amounting to ₹8.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kaushal Shah, Sachin Shah, and Gagan Atreja serve as directors at the Company.
- CIN/LLPIN
U24232GJ2011PLC112374
- Company No.
138758
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aprica Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kaushal Shah  | Director | 01-Oct-2017 | Current |
| Sachin Shah | Director | 01-Oct-2017 | Current |
| Gagan Atreja | Director | 28-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Aprica Healthcare.
Aprica Healthcare Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.83% decrease. The company also saw a substantial fall in profitability, with a 57.61% decrease in profit. The company's net worth moved up by a moderate rise of 4.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aprica Healthcare?
In 2023, Aprica Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Eris Healthcare Private LimitedActive 11 years 6 months
Kaushal Shah and Sachin Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharashtra Creation Date: 06 Jan 2016 | ₹4.00 Cr | Satisfied |
Bank Of Maharashtra Creation Date: 29 Sep 2011 | ₹4.00 Cr | Satisfied |
How Many Employees Work at Aprica Healthcare?
Unlock and access historical data on people associated with Aprica Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aprica Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprica Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
